Posted: September 27th, 2019
Biogen v. Swiss Pharma, Court of Appeal of The Hague 10 September 2019 Biogen MA Inc (“Biogen”) is a pharmaceutical company marketing numerous medicinal products including Tysabri (or Antegren). The active pharmaceutical ingredient of Tysabri is natalizumab, which in turn is a humanized monoclonal antibody against the cell adhesion molecule α4-integrin. Swiss Pharma International AG […]
READ MORE
Posted: September 25th, 2019
Adaptive Spectrum And Signal Alignment Inc. v. Koninklijke KPN N.V., KPN B.V., Telfort Zakelijk B.V., XS4ALL Internet B.V. and Nokia Solutions and Networks Nederland B.V., District Court The Hague, 25 September 2019, Case no. C/09/563488 / HA-ZA 18-1176 On 25 September 2019 the District Court of The Hague rendered a final judgment in the case […]
READ MORE
Posted: September 23rd, 2019
Bayer Intellectual Property GmbH and Bayer Animal Health GmbH v. Ceva Santé Animale SA. and Ceva Santé Animale B.V., District Court The Hague, The Netherlands, 17 September 2019, Case No. ECLI:NL:RBDHA:2019:9764 Reasonable chance that Bayer’s patent will be invalidated by the Technical Board of Appeal or in proceedings on the merits, despite the earlier decision […]
READ MORE
Posted: September 19th, 2019
The 9th edition of the Case Law of the Boards of Appeal is now available on the EPO website. The PDF version can be accessed here. A printed version can still be ordered and will be available mid September.
READ MORE
Posted: September 18th, 2019
CJEU preliminary ruling judgment in C-688/17 (Bayer) provides interpretation on Art. 9 (7) of the Directive 48/2004/EC (Enforcement Directive) based on a referral from the Hungarian court On September 12, 2019 the Court of Justice laid down its decision in C-688/17 (Bayer) in a preliminary ruling proceeding coming from the Metropolitan Court, Budapest, about the […]
READ MORE
Posted: September 17th, 2019
Eli Lilly and Company v. Genentech Inc., Reference for a preliminary ruling, 5 September 2019, Case C‑239/19 “[T]he justification for a reference for a preliminary ruling is not that it enables such opinions to be delivered but rather that it is necessary for the effective resolution of a dispute concerning EU law (judgment of 13 […]
READ MORE
Posted: September 12th, 2019
Ratification of the UPC Agreement by Germany: Waiting for Godot? By Dr. Tobias Wuttke and Carolin Stenz, Meissner Bolte With its response dated 31 July 2019 to the brief parliamentary enquiry (in the following “Brief Inquiry”) of the German Parliament’s Liberal Party (“FDP”), the German Federal Government has fuelled new speculation of potential delays of the […]
READ MORE
Posted: September 12th, 2019
Joined Cases C‑650/17 and C‑114/18, Royalty Pharma Collection Trust joined party Deutsches Patent- und Markenamt (Request for a preliminary ruling from the Bundespatentgericht (Germany)) and Sandoz Ltd, Hexal AG v. G.D. Searle LLC, Janssen Sciences Ireland (Request for a preliminary ruling from the Court of Appeal (England & Wales), Opinion of Advocate General Hogan, 11 September […]
READ MORE
Posted: September 10th, 2019
The EPLAW General Assembly and Congress will be held on 29 November 2019 in Brussels. The agenda and details for registration will be provided to EPLAW members separately. As in previous years, a reception will be held on the evening before the Congress.
READ MORE
Posted: September 9th, 2019
The EPLAW Board is glad to inform that Pierre Véron, Honorary President of EPLAW, will be speaking at the WIPO Arbitration and Mediation workshop to be held in Paris on 7 November 2019. EPLAW is a sponsor of this event. If you would like more information on this event and/or would like to apply, please […]
READ MORE
EMAIL US
